Member

Login to your account, make a payment, see benefits and more.

Members

Manage Your Plan

Helpful Tools

Wellcare By Fidelis Care

Members
Providers

Login to your account, download forms, view auth grids and more.

Providers

Provider Resources

About Our Plans

Helpful Tools

Providers
Shop For a Plan

See plan benefits, coverage areas, get a quote and more.

Shop for a Plan

Our Plans

Helpful Tools

Wellcare By Fidelis Care

Shop for a Plan
AAA
HomeMemberHelpful ToolsHealth ResourcesSocial Determinants of HealthGiving Back

Giving Back to Our Communities

Fidelis Care and the Centene Foundation Award $1.1 Million to The Jed Foundation to Protect the Mental Health of New York’s Youth

Funding will help expand emotional well-being resources, educational workshops, and training programs for community-based organizations that foster communities of care statewide

September 20, 2024, NEW YORK CITY —  Fidelis Care, a leading health insurer providing quality, affordable coverage to New Yorkers, and the Centene Foundation, the philanthropic arm of Centene Corporation, announced today a $1.1 million grant to The Jed Foundation (JED), a national nonprofit that protects emotional health and prevents suicide for teens and young adults.

With this grant, JED will expand its current services, providing at least five youth-serving community-based organizations (CBOs) with consultation or strategic planning services, including expert guidance, educational workshops, and training programs, equipping young people with life skills and connecting them to mental health care when they are in distress.

“We are thrilled to support the vital work of The Jed Foundation with this grant,” said Vincent Marchello, Chief Medical Officer at Fidelis Care. “At Fidelis Care, we recognize the importance of mental health services in creating healthier communities. This investment underscores our commitment to ensuring youth and adolescents have access to the critical support they need to thrive.”

According to the Substance Abuse and Mental Health Services Administration (SAMHSA), it is currently estimated that nearly one in five 12- to 17-year-olds in the United States experience a major depressive episode every year, and almost half of teens 13 to 17 say they would seek out professional help only as a last resort. In New York State, the need for enhanced mental health support for school-aged youth is critical: in 2021, 57% of New York 12- to 17-year-olds with depression had not received any care in the last year.

“JED is grateful to Fidelis Care and the Centene Foundation for their commitment to supporting the emotional well-being of New York youth and for providing the resources to help them thrive,” said John MacPhee, JED Chief Executive Officer. “This partnership will allow us to bring JED’s lifesaving work to community-based organizations across the state and help them build on their mental health safety nets and approaches, while positively impacting the lives of thousands of young people.”

The inaugural group of CBOs includes Bottom Line, an organization that partners with degree-aspiring students from first-generation and low-income backgrounds as they get into and through college and launch mobilizing first careers; Hetrick-Martin Institute, which provides free, year-round programs and services for LGBTQIA+ youth and allies aged 13 to 24 in New York City; and Prep for Prep, which provides first-rate educational, leadership development and professional advancement opportunities for young people of color in New York City.

"Through decades of experience at Bottom Line, we have seen that the condition of a student's mental health plays a significant role in their overall journey to becoming a college graduate and professional,” said Sheneita R. Graham, Director of Culturally Responsive Programming at Bottom Line. “Our role at Bottom Line is to build strong relationships that assist us in determining need and connecting students to resources that will help them thrive personally to persist academically. Partnering with The Jed Foundation grants us the opportunity to expertly assess our mental health policies, processes, and resources to ensure we provide our students with thoughtful, high-quality support."

"Hetrick-Martin Institute is pleased to be working with The Jed Foundation to improve our ability to recognize young people in distress and conduct suicide risk assessments," said Bridget Hughes, Chief Program Officer at Hetrick-Martin Institute.

"We are so grateful to The Jed Foundation for hosting two workshops for our incoming college freshmen as part of our annual College Transition Retreat,” said Corey Rhoades, Director of Undergraduate Affairs at Prep for Prep. “The presenters shared their expertise and tailored the sessions in a way that was uniquely relevant and engaging for our students."

To learn more about ways to provide community-based organizations with consulting, evidence-based best practices, and data-driven guidance to protect youth mental health and prevent suicide, visit JED’s website.

Fidelis-JED-Social

Screener Program Provides Support to Families Impacted by Social Determinants of Health

SDoH-chart

Fidelis Care’s innovative SDoH screener program was launched two years ago as a grassroots health equity initiative to address conditions in the environments where people are born, live, work, and play that affect their health, well-being, and quality of life. Social Determinants of Health can affect a wide range of health risks and outcomes – particularly among vulnerable populations and in underserved areas.

The screener enables trained Fidelis Care representatives to assess an individual’s immediate needs and challenges related to SDoH through a brief series of questions covering areas such as access to transportation, food, and secure and safe housing. More than 450,000 Fidelis Care members have participated to date.


Click here to learn more about the different Social Determinants of Health and find available resources.

More News:


Cervical Cancer Screening and Prevention: What You Need To Know
1/24/2022 • Posted by Dr. Jeannine Villella, GYN Oncologist at Northwell in Corporate News, Health and Wellness, Women's Health

Living-with-Sickle-Cell-Fidelis-Care-Support

Cervical Cancer affects women worldwide.  This unfortunate disease affects over 14,000 women per year in the United States. The age of cervical cancer varies, but in the United States the average age of diagnosis is 50 years old. 

In many cases, this is a curative disease, however in advanced stages the five year survival is less than 50%. Thus, it is especially important to learn about screening cervical cancer and prevention because there are ways to decrease your chance of suffering from this disease. Cervical cancer prevention, screening, treatment are critical components of comprehensive reproductive health care.

HUMAN PAPILLOMA VIRUS (HPV)

Most cases of cervical cancer are due to a sexually transmitted virus called the human papilloma virus. This virus is very prevalent among both men and women, and has been responsible for many cancers of cervix, tonsils, mouth, throat, anus, vulva to name a few.  There are over 100 different HPV viruses. One of the ways you can protect yourself and others is to receive the HPV vaccine. These vaccines protect against 4 or 9 of the most common HPV types that cause cervical cancer.  This vaccine is now approved for anyone from the age of 9-45 years of age of any gender or sexual orientation. Speak to your health care provider to learn more!

CERVICAL CYTOLOGY

Cervical cytology (a pap smear) is the screening method to detect cervical cancer or precancer.  It is very effective in detecting these lesions and has been responsible for the decreased number of cervical cancers in the country.  This test is done by health care providers with use of a speculum placed in the vagina to visualize the cervix.  Then a small brush is placed against the cervix to obtain cervical cells. It may be associated with minimal discomfort, but fortunately it only takes a few seconds to complete.

CURRENT SCREENING GUIDELINES

The American College of Obstetricians and Gynecologists (ACOG), the Society of Gynecologic Oncology (SGO) and the U.S. Preventive Services Task Force (USPTF) created guidelines for screening with high-risk HPV testing and cervical cytology for average risk individuals.  No screening is recommended for age less than 21 years. From age 21-29, cervical cytology alone is recommended.  HPV testing is not recommended in this age group because many people will have HPV but very low risk of having cancer.  From age 30-65 years old people can have cytology alone every 3 years, high risk HPV testing alone every 3 years or cervical cytology and high-risk HPV testing every 5 years. These guidelines do not apply to individuals with previous precancerous lesions or compromised immune system.

The more you know about your body and what is available to you to prevent and screen for cervical cancer, the healthier you will be!

 

References:

  1. SEER: https://seer.cancer.gov.
  2. Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, Davidson KW, et al.  Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement.  U.S. Preventative Services Task Forse. JAMA 2018; 320:674-86.
  3. American College of Obstetricians and Gynecologists.  Updated guidelines for management of cervical cancer screening abnormalities.  Practice Advisory. Washington, DC: American College of Obstetricians and Gynecologists; 2020. Available HERE

 


Cervical Cancer Screening and Prevention: What You Need To Know
1/24/2022 • Posted by Dr. Jeannine Villella, GYN Oncologist at Northwell in Corporate News, Health and Wellness, Women's Health

Living-with-Sickle-Cell-Fidelis-Care-Support

Cervical Cancer affects women worldwide.  This unfortunate disease affects over 14,000 women per year in the United States. The age of cervical cancer varies, but in the United States the average age of diagnosis is 50 years old. 

In many cases, this is a curative disease, however in advanced stages the five year survival is less than 50%. Thus, it is especially important to learn about screening cervical cancer and prevention because there are ways to decrease your chance of suffering from this disease. Cervical cancer prevention, screening, treatment are critical components of comprehensive reproductive health care.

HUMAN PAPILLOMA VIRUS (HPV)

Most cases of cervical cancer are due to a sexually transmitted virus called the human papilloma virus. This virus is very prevalent among both men and women, and has been responsible for many cancers of cervix, tonsils, mouth, throat, anus, vulva to name a few.  There are over 100 different HPV viruses. One of the ways you can protect yourself and others is to receive the HPV vaccine. These vaccines protect against 4 or 9 of the most common HPV types that cause cervical cancer.  This vaccine is now approved for anyone from the age of 9-45 years of age of any gender or sexual orientation. Speak to your health care provider to learn more!

CERVICAL CYTOLOGY

Cervical cytology (a pap smear) is the screening method to detect cervical cancer or precancer.  It is very effective in detecting these lesions and has been responsible for the decreased number of cervical cancers in the country.  This test is done by health care providers with use of a speculum placed in the vagina to visualize the cervix.  Then a small brush is placed against the cervix to obtain cervical cells. It may be associated with minimal discomfort, but fortunately it only takes a few seconds to complete.

CURRENT SCREENING GUIDELINES

The American College of Obstetricians and Gynecologists (ACOG), the Society of Gynecologic Oncology (SGO) and the U.S. Preventive Services Task Force (USPTF) created guidelines for screening with high-risk HPV testing and cervical cytology for average risk individuals.  No screening is recommended for age less than 21 years. From age 21-29, cervical cytology alone is recommended.  HPV testing is not recommended in this age group because many people will have HPV but very low risk of having cancer.  From age 30-65 years old people can have cytology alone every 3 years, high risk HPV testing alone every 3 years or cervical cytology and high-risk HPV testing every 5 years. These guidelines do not apply to individuals with previous precancerous lesions or compromised immune system.

The more you know about your body and what is available to you to prevent and screen for cervical cancer, the healthier you will be!

 

References:

  1. SEER: https://seer.cancer.gov.
  2. Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, Davidson KW, et al.  Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement.  U.S. Preventative Services Task Forse. JAMA 2018; 320:674-86.
  3. American College of Obstetricians and Gynecologists.  Updated guidelines for management of cervical cancer screening abnormalities.  Practice Advisory. Washington, DC: American College of Obstetricians and Gynecologists; 2020. Available HERE